Business Context and Reporting Period
Company: Linde plc
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Linde is the world's largest industrial gas company, producing atmospheric gases (oxygen, nitrogen, argon) and process gases (hydrogen, helium, carbon dioxide). Operations are managed across three geographic segments (Americas, EMEA, APAC) and an Engineering segment. The company serves diverse industries including healthcare, chemicals, energy, manufacturing, and electronics.
Key Financial Metrics
| Metric (Millions USD) | 2024 | 2023 | Variance |
|---|---|---|---|
| Sales | $33,005 | $32,854 | Flat (0%) |
| Operating Profit (Reported) | $8,635 | $8,024 | +8% |
| Operating Profit (Adjusted) | $9,720 | $9,070 | +7% |
| Net Income - Linde plc | $6,565 | $6,199 | +6% |
| Diluted EPS (Reported) | $13.62 | $12.59 | +8% |
| Diluted EPS (Adjusted) | $15.51 | $14.20 | +9% |
| Cash Flow from Operations | $9,423 | $9,305 | +$118M |
| Capital Expenditures | $4,497 | $3,787 | +$710M |
| Net Debt | $16,773 | $14,709 | +$2,064M |
| Adjusted EBITDA | $12,819 | $12,133 | +6% |
Material Changes vs. Prior Period
- Revenue Drivers: Sales were flat year-over-year. A 2% increase from higher price attainment (primarily in Americas and EMEA) was offset by a 1% decrease from cost pass-through and a 1% decrease from currency translation. Volume growth from new project start-ups was neutralized by base volume declines.
- Profitability: Operating profit increased 8% (reported) and 7% (adjusted), driven by higher pricing and productivity savings that outpaced cost inflation and currency headwinds.
- Segment Performance:
- EMEA: Sales decreased 2% due to cost pass-through and lower volumes, but operating profit surged 12% due to pricing and productivity.
- Americas: Sales increased 1% and operating profit increased 7%, driven by pricing and a supplier settlement gain.
- APAC: Sales increased 1% and operating profit increased 6%, driven by volume growth in the electronics market.
- Engineering: Sales increased 8% due to project timing, but operating profit declined 16% due to the absence of prior-year benefits from the wind-down of sanctioned projects in Russia.
- Cost Reduction: Cost reduction program and other charges were $145 million in 2024 (vs. $40 million in 2023), primarily due to severance costs.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: The filing does not contain specific numerical guidance for 2025 within the text provided, noting that quarterly updates are available via earnings releases and investor teleconferences.
- Capital Allocation:
- Dividends: Increased 9% to $5.56 per share ($2,655 million total).
- Share Repurchases: Net purchases of $4,451 million. Under the 2023 program, $3.1 billion has been repurchased with $11.9 billion remaining authorized.
- Key Risks:
- Geopolitical/Legal: Ongoing disputes in Russia regarding engineering projects (RCA claims) resulted in the sale of two Russian joint ventures in Q4 2024. Linde maintains a $1.7 billion liability related to these matters but does not expect a material adverse impact on earnings.
- Energy Costs: Energy is the largest cost item; while pass-through clauses exist, volatility remains a risk.
- Currency: Significant exposure to foreign exchange fluctuations (Euro, Chinese Yuan, Brazilian Real, Mexican Peso).
- Goodwill: Carrying value of goodwill is approximately $26 billion; impairment risks exist if market capitalization declines significantly.
- Unusual Items:
- Other Income: Included a $41 million benefit from a supplier settlement in the Americas and $45 million in insurance recoveries.
- Pension: Actuarial gains in 2024 due to higher discount rates resulted in a net pension benefit of $190 million.
Investor Verification Checklist
- Price Realization vs. Volume: Verify the sustainability of the 2% price increase given the flat volume environment and potential customer pushback.
- Engineering Backlog: Confirm the $7.1 billion backlog of large projects under construction and the timeline for revenue recognition.
- Russia Exposure: Monitor the status of the $1.7 billion liability and the outcome of arbitration proceedings with RusChemAlliance (RCA).
- Debt Maturity Profile: Review the schedule of debt maturities, noting significant issuances in 2024 and 2025 to manage refinancing risk.
- Cost Reduction Execution: Assess the impact of the $145 million in cost reduction charges on future operating margins and workforce stability.